209 related articles for article (PubMed ID: 24428217)
1. Association of transforming growth factor-β1 T869C gene polymorphism with diabetic nephropathy risk.
Zhou TB; Jiang ZP; Qin YH; Drummen GP
Nephrology (Carlton); 2014 Feb; 19(2):107-15. PubMed ID: 24428217
[TBL] [Abstract][Full Text] [Related]
2. Association of transforming growth factor-β1 T869C, G915C, and C509T gene polymorphisms with rheumatoid arthritis risk.
Zhou TB; Zhao HL; Fang SL; Drummen GP
J Recept Signal Transduct Res; 2014 Dec; 34(6):469-75. PubMed ID: 24840097
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of the association of G915C, G800A, C509T gene polymorphism of transforming growth factor-β1 with diabetic nephropathy risk.
Zhang J; Guan YL; Xiao Y; Zhang XW
Ren Fail; 2014 Mar; 36(2):321-6. PubMed ID: 24060183
[TBL] [Abstract][Full Text] [Related]
4. Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy.
El-Sherbini SM; Shahen SM; Mosaad YM; Abdelgawad MS; Talaat RM
Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):330-8. PubMed ID: 23399816
[TBL] [Abstract][Full Text] [Related]
5. Association Between Transforming Growth Factor-β1 T869C Gene Polymorphism and Diabetic Nephropathy: A Meta-Analysis in the Chinese Population.
Zhou D; Mou X; Liu K; Liu W; Xu Y; Zhou D
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307180
[TBL] [Abstract][Full Text] [Related]
6. Association of T869, C509T, G915C gene polymorphism of transforming growth factor-β1 with IgA nephropathy risk.
Zhou TB; Guo XF; Yin SS
Ren Fail; 2014 Jun; 36(5):823-8. PubMed ID: 24564406
[TBL] [Abstract][Full Text] [Related]
7. Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population.
Zhou T; Li HY; Zhong H; Zhong Z
BMC Med Genet; 2018 Nov; 19(1):201. PubMed ID: 30458730
[TBL] [Abstract][Full Text] [Related]
8. Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-β1 (T869C) gene polymorphism.
Mou X; Liu WH; Zhou DY; Liu YH; Hu YB; Ma GL; Shou CM; Chen JW; Zhao JX
Chin J Integr Med; 2011 Sep; 17(9):680-4. PubMed ID: 21910069
[TBL] [Abstract][Full Text] [Related]
9. The transforming growth factor-β1 (TGF-β1) gene polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and susceptibility to postmenopausal osteoporosis: a meta-analysis.
Sun J; Zhang C; Xu L; Yang M; Yang H
Medicine (Baltimore); 2015 Jan; 94(4):e461. PubMed ID: 25634187
[TBL] [Abstract][Full Text] [Related]
10. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
[TBL] [Abstract][Full Text] [Related]
11. Significant correlation between association of polymorphism in codon 10 of transforming growth factor-beta1 T (29) C with type 1 diabetes and patients with nephropathy disorder.
Jahromi MM; Millward BA; Demaine AG
J Interferon Cytokine Res; 2010 Feb; 30(2):59-66. PubMed ID: 20039825
[TBL] [Abstract][Full Text] [Related]
12. Different Risk Indictors of Diabetic Nephropathy in Transforming Growth Factor-beta1 T869C CC/CT Genotype and TT Genotype.
Mou X; Liu Y; Zhou D; Hu Y; Ma G; Shou C; Chen J; Zhou D
Iran J Public Health; 2016 Jun; 45(6):761-7. PubMed ID: 27648419
[TBL] [Abstract][Full Text] [Related]
13. Association of T869C gene polymorphism of transforming growth factor-β1 with low protein levels and anthropometric indices in osteopenia/osteoporosis postmenopausal Thai women.
Utennam D; Tungtrongchitr A; Phonrat B; Tungtrongchitr R; Preutthipan S
Genet Mol Res; 2012 Jan; 11(1):87-99. PubMed ID: 22290469
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G; Shan B
Int J Immunogenet; 2011 Jun; 38(3):215-24. PubMed ID: 21205231
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
Yu ZY; Chen LS; Zhang LC; Zhou TB
Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
[TBL] [Abstract][Full Text] [Related]
16. Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis.
Jia H; Yu L; Gao B; Ji Q
Endocrine; 2011 Dec; 40(3):372-8. PubMed ID: 21725704
[TBL] [Abstract][Full Text] [Related]
17. Association of monocyte chemoattractant protein-1 2518G/A gene polymorphism with diabetic nephropathy risk.
Su N; Li HY; Huang MF; Jiang ZP; Zhou TB
J Recept Signal Transduct Res; 2015 Feb; 35(1):94-7. PubMed ID: 25051493
[TBL] [Abstract][Full Text] [Related]
18. Association between transforming growth factor-beta1 gene C-509T and T869C polymorphisms and rheumatic heart disease.
Chou HT; Chen CH; Tsai CH; Tsai FJ
Am Heart J; 2004 Jul; 148(1):181-6. PubMed ID: 15215809
[TBL] [Abstract][Full Text] [Related]
19. Association between endothelial nitric oxide synthase Glu298Asp gene polymorphism and diabetic nephropathy susceptibility.
Zhou TB; Xu HL; Yin SS
Ren Fail; 2013; 35(1):173-8. PubMed ID: 23113598
[TBL] [Abstract][Full Text] [Related]
20. Association between transforming growth factor-β1gene-509C/T polymorphism and susceptibility of IgA nephropathy: a meta-analysis.
Li Z; Li Y; Chen L
Ren Fail; 2014 Nov; 36(10):1473-80. PubMed ID: 25112155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
